Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-15-182168

← back to feed
Filed
May 11, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 11, 2015 30.83M sh
Operating Cash Flow Q1 2015 · Mar 31, 2015 −$373.92K
Operating Cash Flow Q1 2015 · Mar 31, 2014 −$342.51K
Cash And Equivalents Q1 2015 · Mar 31, 2015 $447.23K
Cash And Equivalents Q1 2015 · Dec 31, 2014 $707.01K
Cash And Equivalents Q1 2015 · Mar 31, 2014 $284.41K
Cash And Equivalents Q1 2015 · Dec 31, 2013 $142.53K
Stockholders Equity Q1 2015 · Mar 31, 2015 −$763.87K
Stockholders Equity Q1 2015 · Dec 31, 2014 −$295.85K
Current Liabilities Q1 2015 · Mar 31, 2015 $1.27M
Current Liabilities Q1 2015 · Dec 31, 2014 $1.04M
Current Assets Q1 2015 · Mar 31, 2015 $480.23K
Current Assets Q1 2015 · Dec 31, 2014 $721.74K
Total Assets Q1 2015 · Mar 31, 2015 $504.29K
Total Assets Q1 2015 · Dec 31, 2014 $748.31K
Sga Expense Q1 2015 · Mar 31, 2015 $560.33K
Sga Expense Q1 2015 · Mar 31, 2014 $583.86K
Rd Expense Q1 2015 · Mar 31, 2015 $227.16K
Rd Expense Q1 2015 · Mar 31, 2014 $484.14K
Net Income Q1 2015 · Mar 31, 2015 −$763.09K
Net Income Q1 2015 · Mar 31, 2014 −$1.17M
Operating Income Q1 2015 · Mar 31, 2015 −$787.49K
Operating Income Q1 2015 · Mar 31, 2014 −$1.07M
Capex Q1 2015 · Mar 31, 2014 $5.62K